ZYVERSA THERAPEUTICS, INC. Deferred Tax Assets, Operating Loss Carryforwards
ZYVERSA THERAPEUTICS, INC. (ZVSA) had Deferred Tax Assets, Operating Loss Carryforwards of $14.42 million as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-31
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $14.42M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $12.54M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $9.97M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $6.67M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $14.42M 10-K · filed 2026-03-31 |
| 2024-12-31 | $12.54M 10-K · filed 2026-03-31 |
| 2023-12-31 | $9.97M 10-K · filed 2025-03-27 |
| 2022-12-31 | $6.67M 10-K · filed 2024-03-25 |
| 2022-12-12 | $6.64M 10-K · filed 2024-03-25 |
| 2021-12-31 | $33.26K 10-K · filed 2022-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |